- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Cytokeratin 16 Antibody LL025 / CK16 Monoclonal Antibody recognizes keratin 16, a type I intermediate filament protein encoded by the KRT16 gene. Cytokeratin 16 is expressed in selected stratified squamous epithelia, where it contributes to the organization and mechanical stability of epithelial cells. Its expression is particularly associated with specialized epithelial compartments and tissues undergoing increased proliferation or remodeling. Changes in KRT16 expression provide information about epithelial differentiation and the response of keratinocytes to physiological and pathological stimuli.
In normal tissues, KRT16 is found in specific regions of stratified squamous epithelium, including specialized epithelial structures exposed to mechanical stress. It is also expressed in selected glandular epithelial populations, including sweat ducts. Keratin 16 frequently forms intermediate filament networks with keratin 6, supporting cytoskeletal organization during epithelial activation. Its distribution differs from that of keratins associated primarily with terminal differentiation, making it useful for examining distinct epithelial phenotypes.
In surgical pathology, Cytokeratin 16 expression has been investigated in squamous cell carcinomas, particularly tumors arising in the head and neck. Alterations in keratin expression accompany changes in epithelial differentiation and may help characterize the phenotype of neoplastic cells. However, KRT16 is not specific for malignancy, and its presence must be interpreted alongside histological features and additional epithelial markers. Reactive epithelial hyperplasia and inflammatory conditions can also produce increased KRT16 expression.
Keratin 16 is additionally associated with epidermal activation during wound healing and inflammatory skin disease. In psoriasis, its expression expands within affected epidermis as keratinocytes adopt an altered differentiation program. Mutations in KRT16 are also responsible for certain forms of pachyonychia congenita, demonstrating the importance of this protein in maintaining epithelial integrity under mechanical stress.
NSJ Bioreagents provides Cytokeratin 16 Antibody LL025 for immunohistochemical investigation of human tissues. This mouse monoclonal antibody recognizes a C-terminal region of KRT16 and supports studies examining epithelial differentiation and pathological changes in keratin expression. The CK16 Monoclonal Antibody is relevant to research involving squamous epithelial tumors, dermatological disorders, and the organization of specialized epithelial tissues.
Explore our Keratin 16 Antibody KRT16/2043R for additional research into KRT16 expression, epithelial differentiation, and keratinocyte responses to tissue injury and inflammation.
Optimal dilution of the Cytokeratin 16 Antibody LL025 / CK16 Monoclonal Antibody should be determined by the researcher.
An amino acid sequence from the C-terminal region of the protein was used as the immunogen for this Cytokeratin 16 antibody.
Store the Cytokeratin 16 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Keratin 16 antibody, KRT16 antibody, CK16 antibody, Keratin-16 antibody, Cytokeratin-16 antibody, K16 antibody, Cytokeratin 16 Monoclonal antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.